Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases.
暂无分享，去创建一个
H. Xu | Xiaotun Zhang | M. Bowman | Xiaohong Li | Jingchen Cao | Xiangqi Meng | Z. Madaj | Haiquan Yu | Shang Su | Rui-hua Liu | Yingying Wu | A. V. Ark | Erica Woodford | Reian Zhang | Isabelle Stiver | Bin Chen | Ruihua Liu